Institutional investors hold a majority ownership of AGN through the 88.75% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended September 2013, these large investors purchased a net $3.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JENNISON ASSOCIATES LLC Bought 2.7 Million shares of Allergan Inc
OPPENHEIMERFUNDS, INC. Bought 2.7 Million shares of Allergan Inc
VISIUM ASSET MANAGEMENT LP Bought 1.6 Million shares of Allergan Inc